, India

India approves 20% FDI for LIC $8b IPO—report

IPO is set to launch in March.

India’s cabinet has approved a policy amendment allowing foreign direct investments (FDIs) of up to 20% in state-owned insurer Life Insurance Corporation, a report by Reuters said.

India is set to sell 5% of its shares in March to raise $8b.

ALSO READ: India state-run LIC files $8b IPO papers

The amendment would allow foreign direct investors to buy 20% of LIC’s shares through an automatic route.

In India’s current rules, FDIs is not allowed in LIC, which is governed by the special parliament act, whilst 74% foreign direct investment is allowed in other private insurance companies.

 said the government source, who spoke on condition of anonymity after the cabinet meeting.

Under current rules, foreign investment is not allowed in the LIC, governed by the special parliament act, while 74% foreign direct investment is allowed in other private insurance companies.

The amendment would allow the government to raise the foreign direct investment limit in the LIC up to 20%, on par with the rule for state-run banks, the report said.

You may also like:

LIC prospective investors wary of govt’ meddling in the insurer

AIA sells Australian savings and investment business

Hong Kong insurance regulator warns public against phishing scams

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.